BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

439 related articles for article (PubMed ID: 30027226)

  • 1. Association of Tumor Size With Histologic and Clinical Outcomes Among Patients With Cytologically Indeterminate Thyroid Nodules.
    Valderrabano P; Khazai L; Thompson ZJ; Otto KJ; Hallanger-Johnson JE; Chung CH; Centeno BA; McIver B
    JAMA Otolaryngol Head Neck Surg; 2018 Sep; 144(9):788-795. PubMed ID: 30027226
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Preoperative Role of RAS or BRAF K601E in the Guidance of Surgery for Indeterminate Thyroid Nodules.
    Ravella L; Lopez J; Descotes F; Giai J; Lapras V; Denier ML; Borson-Chazot F; Lifante JC; Decaussin-Petrucci M
    World J Surg; 2020 Jul; 44(7):2264-2271. PubMed ID: 32227276
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diagnosis, treatment, and outcome of follicular thyroid carcinoma.
    Emerick GT; Duh QY; Siperstein AE; Burrow GN; Clark OH
    Cancer; 1993 Dec; 72(11):3287-95. PubMed ID: 8080485
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ultrasonographic features associated with malignancy in cytologically indeterminate thyroid nodules.
    Batawil N; Alkordy T
    Eur J Surg Oncol; 2014 Feb; 40(2):182-6. PubMed ID: 24373298
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Does Hurthle cell lesion/neoplasm predict malignancy more than follicular lesion/neoplasm on thyroid fine-needle aspiration?
    Pu RT; Yang J; Wasserman PG; Bhuiya T; Griffith KA; Michael CW
    Diagn Cytopathol; 2006 May; 34(5):330-4. PubMed ID: 16604553
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A risk model to determine surgical treatment in patients with thyroid nodules with indeterminate cytology.
    Macias CA; Arumugam D; Arlow RL; Eng OS; Lu SE; Javidian P; Davidov T; Trooskin SZ
    Ann Surg Oncol; 2015 May; 22(5):1527-32. PubMed ID: 25388058
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Thyroid nodules with indeterminate cytology: association between nodule size, histopathological characteristics and clinical outcome in differentiated thyroid carcinomas - a multicenter retrospective cohort study on 761 patients.
    Cozzani F; Bettini D; Rossini M; Bonati E; Nuzzo S; Loderer T; Pedrazzi G; Zaccaroni A; Del Rio P
    Updates Surg; 2021 Oct; 73(5):1923-1930. PubMed ID: 34100186
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cytopathology-histopathology correlation and the effect of nodule diameter on diagnostic performance in patients undergoing thyroid fine-needle aspiration biopsy.
    Yilmaz N; Cansu GB; Toru S; Sari R; Ocak GG; Arici C; Altunbas HA; Balci MK
    J Cancer Res Ther; 2020 Dec; 16(Supplement):S53-S58. PubMed ID: 33380652
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Extending expressed RNA genomics from surgical decision making for cytologically indeterminate thyroid nodules to targeting therapies for metastatic thyroid cancer.
    Ali SZ; Siperstein A; Sadow PM; Golding AC; Kennedy GC; Kloos RT; Ladenson PW
    Cancer Cytopathol; 2019 Jun; 127(6):362-369. PubMed ID: 31017745
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Follow-Up or Surgery for Indeterminate Thyroid Nodules: Could the CUT Score Application Be a Support for Decision-Making in the Preoperative Assessment?
    Ianni F; Pascucci D; Paragliola RM; Rota CA; Perotti G; Fadda G; Pontecorvi A; Corsello SM
    Thyroid; 2020 Jan; 30(1):65-71. PubMed ID: 31552809
    [No Abstract]   [Full Text] [Related]  

  • 11. Afirma Gene Sequencing Classifier Compared with Gene Expression Classifier in Indeterminate Thyroid Nodules.
    Endo M; Nabhan F; Porter K; Roll K; Shirley LA; Azaryan I; Tonkovich D; Perlick J; Ryan LE; Khawaja R; Meng S; Phay JE; Ringel MD; Sipos JA
    Thyroid; 2019 Aug; 29(8):1115-1124. PubMed ID: 31154940
    [No Abstract]   [Full Text] [Related]  

  • 12. Follicular neoplasms of the thyroid: diagnostic and operative management.
    Bernante P; Toniato A; Piotto A; Gemo G; Pagetta C; Bernardi C; Pelizzo MR
    J Exp Clin Cancer Res; 1998 Mar; 17(1):125-6. PubMed ID: 9646248
    [No Abstract]   [Full Text] [Related]  

  • 13.
    Ciappuccini R; Licaj I; Lasne-Cardon A; Babin E; de Raucourt D; Blanchard D; Bastit V; Saguet-Rysanek V; Lequesne J; Peyronnet D; Grellard JM; Clarisse B; Bardet S
    Thyroid; 2021 May; 31(5):800-809. PubMed ID: 33183159
    [No Abstract]   [Full Text] [Related]  

  • 14. Validation of American Thyroid Association Ultrasound Risk Assessment of Thyroid Nodules Selected for Ultrasound Fine-Needle Aspiration.
    Tang AL; Falciglia M; Yang H; Mark JR; Steward DL
    Thyroid; 2017 Aug; 27(8):1077-1082. PubMed ID: 28657511
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Digital image-assisted quantitative nuclear analysis improves diagnostic accuracy of thyroid fine-needle aspiration cytology.
    Chain K; Legesse T; Heath JE; Staats PN
    Cancer Cytopathol; 2019 Aug; 127(8):501-513. PubMed ID: 31150162
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Follicular nodules (Thy3) of the thyroid: is total thyroidectomy the best option?
    Calò PG; Medas F; Santa Cruz R; Podda F; Erdas E; Pisano G; Nicolosi A
    BMC Surg; 2014 Mar; 14():12. PubMed ID: 24597765
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic Value of Preoperative Molecular Testing and Implications for Initial Surgical Management in Thyroid Nodules Harboring Suspected (Bethesda V) or Known (Bethesda VI) Papillary Thyroid Cancer.
    Schumm MA; Shu ML; Hughes EG; Nikiforov YE; Nikiforova MN; Wald AI; Lechner MG; Tseng CH; Sajed DP; Wu JX; Yeh MW; Livhits MJ
    JAMA Otolaryngol Head Neck Surg; 2023 Aug; 149(8):735-742. PubMed ID: 37382944
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ultrasound and cytological characteristics of non-invasive follicular thyroid neoplasm with papillary-like nuclear features compared to papillary carcinomas.
    Boursier L; Clerc Urmes I; Garon J; Klein M; Demarquet L
    Ann Endocrinol (Paris); 2020 Feb; 81(1):28-33. PubMed ID: 32081363
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diagnostic Lobectomy for Bethesda III Thyroid Nodules: Pathological Outcomes and Risk Factors for Malignancy.
    Walters BK; Garrett SL; Aden JK; Williams GM; Butler-Garcia SL; Newberry TR; Mckinlay AJ
    Ann Otol Rhinol Laryngol; 2021 Sep; 130(9):1064-1068. PubMed ID: 33567896
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Thyroglobulin antibodies as a potential predictive marker of papillary thyroid carcinoma in patients with indeterminate cytology.
    Karatzas T; Vasileiadis I; Zapanti E; Charitoudis G; Karakostas E; Boutzios G
    Am J Surg; 2016 Nov; 212(5):946-952. PubMed ID: 27324384
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.